Trial Profile
A randomised, 2-part, open-label, crossover phase I study investigating four sustained release formulations of ONO 5334 with different pharmacokinetic patterns in healthy postmenopausal women
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 17 Oct 2016
Price :
$35
*